Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
MK Crow - Annals of the rheumatic diseases, 2023 - ard.bmj.com
Research elucidating the pathogenesis of systemic lupus erythematosus (SLE) has defined
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …
Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
MK Crow - Annals of the rheumatic diseases, 2023 - pubmed.ncbi.nlm.nih.gov
Research elucidating the pathogenesis of systemic lupus erythematosus (SLE) has defined
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …
Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
MK Crow - Annals of the Rheumatic Diseases, 2023 - search.proquest.com
Research elucidating the pathogenesis of systemic lupus erythematosus (SLE) has defined
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …
Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
MK Crow - Annals of the Rheumatic Diseases, 2023 - ard.bmj.com
Research elucidating the pathogenesis of systemic lupus erythematosus (SLE) has defined
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …
[PDF][PDF] Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
MK Crow - Ann Rheum Dis, 2023 - sostelemedicina.ucv.ve
Research elucidating the pathogenesis of systemic lupus erythematosus (SLE) has defined
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …
Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets.
MK Crow - Annals of the Rheumatic Diseases, 2023 - europepmc.org
Research elucidating the pathogenesis of systemic lupus erythematosus (SLE) has defined
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …
Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
MK Crow - Annals of the Rheumatic Diseases, 2023 - search.proquest.com
Research elucidating the pathogenesis of systemic lupus erythematosus (SLE) has defined
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …
two critical families of mediators, type I interferon (IFN-I) and autoantibodies targeting nucleic …